Preparation and in Vitro Evaluation of New Composite Mesh Functionalized with Cationic Antimicrobial Peptide

Overview

Journal Materials (Basel)

Publisher MDPI

Date 2019 May 26

PMID 31126063

Authors

Pengbi Liu

Nanliang Chen

Jinhua Jiang

Xuejun Wen

Affiliations

Soon will be listed here.

Abstract

Infection caused by bacteria in hernia repair site is a severe complication, and patients have to undergo a second surgery to remove the infected prosthesis. In this study, we developed a composite biological safe mesh with antibacterial activity. The composite mesh is composed of large pore polypropylene (PP) mesh, poly-caprolactone (PCL) and antimicrobial peptide (PEP-1), which we synthesized in our lab. Fourier transformed infrared (FTIR) spectroscopy was utilized to analyze the functional groups. The surface morphology, in vitro release characters, mechanical properties, antibacterial activities, and in vitro cytotoxicity of modified mesh were evaluated. Results showed that PEP-1 was loaded in fibers successfully and could diffuse from nanofibers to inhibit bacteria () growth. However, the modified mesh did not show inhibition to . The mechanical properties of fabricated mesh showed no difference with two commercial surgical meshes. What is more, modified mesh was proved to be nontoxic to human dermal fibroblasts, indicating that this method to fabricate meshes with antibacterial activity is feasible and provides a new strategy for the development of surgical meshes.

References

. Mesh compared with non-mesh methods of open groin hernia repair: systematic review of randomized controlled trials. Br J Surg. 2000; 87(7):854-9. DOI: 10.1046/j.1365-2168.2000.01539.x. View

Luijendijk R, Hop W, van den Tol M, de Lange D, Braaksma M, Ijzermans J . A comparison of suture repair with mesh repair for incisional hernia. N Engl J Med. 2000; 343(6):392-8. DOI: 10.1056/NEJM200008103430603. View

Stewart P, Costerton J . Antibiotic resistance of bacteria in biofilms. Lancet. 2001; 358(9276):135-8. DOI: 10.1016/s0140-6736(01)05321-1. View

Zasloff M . Antimicrobial peptides of multicellular organisms. Nature. 2002; 415(6870):389-95. DOI: 10.1038/415389a. View

Hancock R . Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis. 2002; 1(3):156-64. DOI: 10.1016/S1473-3099(01)00092-5. View

Deligiannidis N, Papavasiliou I, Sapalidis K, Kesisoglou I, Papavramidis S, Gamvros O . The use of three different mesh materials in the treatment of abdominal wall defects. Hernia. 2002; 6(2):51-5. DOI: 10.1007/s10029-002-0054-4. View

Berger D, Bientzle M, Muller A . Postoperative complications after laparoscopic incisional hernia repair. Incidence and treatment. Surg Endosc. 2002; 16(12):1720-3. DOI: 10.1007/s00464-002-9036-y. View

Hancock R, Patrzykat A . Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr Drug Targets Infect Disord. 2002; 2(1):79-83. DOI: 10.2174/1568005024605855. View

Yeaman M, Yount N . Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev. 2003; 55(1):27-55. DOI: 10.1124/pr.55.1.2. View

10.

USHER F, Ochsner J, TUTTLE Jr L . Use of marlex mesh in the repair of incisional hernias. Am Surg. 1958; 24(12):969-74. View

11.

Bandekar J . Amide modes and protein conformation. Biochim Biophys Acta. 1992; 1120(2):123-43. DOI: 10.1016/0167-4838(92)90261-b. View

12.

Cobb W, Harris J, Lokey J, McGill E, Klove K . Incisional herniorrhaphy with intraperitoneal composite mesh: a report of 95 cases. Am Surg. 2003; 69(9):784-7. View

13.

Bernardo K, Pakulat N, Fleer S, Schnaith A, Utermohlen O, Krut O . Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression. Antimicrob Agents Chemother. 2004; 48(2):546-55. PMC: 321544. DOI: 10.1128/AAC.48.2.546-555.2004. View

14.

Basoglu M, Yildirgan M, Yilmaz I, Balik A, Celebi F, Atamanalp S . Late complications of incisional hernias following prosthetic mesh repair. Acta Chir Belg. 2004; 104(4):425-8. View

15.

Brogden K . Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat Rev Microbiol. 2005; 3(3):238-50. DOI: 10.1038/nrmicro1098. View

16.

Robinson T, Clarke J, Schoen J, Walsh M . Major mesh-related complications following hernia repair: events reported to the Food and Drug Administration. Surg Endosc. 2005; 19(12):1556-60. DOI: 10.1007/s00464-005-0120-y. View

17.

Hancock R, Sahl H . Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol. 2006; 24(12):1551-7. DOI: 10.1038/nbt1267. View

18.

Park S, Kim M, Hossain M, Shin S, Kim Y, Stella L . Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Biochim Biophys Acta. 2007; 1778(1):229-41. DOI: 10.1016/j.bbamem.2007.09.020. View

19.

Swenson B, Camp T, Mulloy D, Sawyer R . Antimicrobial-impregnated surgical incise drapes in the prevention of mesh infection after ventral hernia repair. Surg Infect (Larchmt). 2008; 9(1):23-32. DOI: 10.1089/sur.2007.021. View

20.

Bueno Lledo J, Sosa Quesada Y, Gomez I Gavara I, Vaque Urbaneja J, Carbonell Tatay F, Bonafe Diana S . [Prosthetic infection after hernioplasty. Five years experience]. Cir Esp. 2009; 85(3):158-64. DOI: 10.1016/j.ciresp.2008.09.008. View